House bill · H.R. 8857 (119th Congress)
Next GEN Act of 2026
U.S. House of Representatives
Sponsor: Joseph D. Morelle (U.S. Representative, NY-25, Democratic)
Following needs an Agora account. You will sign in first, then come back to this page.
From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data
Summary
Would amend the Social Security Act to change how engineered cyclic peptides are treated as qualifying single source drugs under the Medicare Drug Price Negotiation Program.
AI summary. Not an official summary. How we handle summaries
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
House Committee on Energy and Commerce · U.S. House of Representatives
Also referred to House Committee on Ways and Means · U.S. House of Representatives.
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Cosponsors
3
Cosponsors listed on Congress.gov, shown A to Z.
- Republican2
- Democratic1
This bill has cosponsors from more than one party.
Shown in neutral colors by design; Agora is non-partisan.
Full history
- May 15, 2026
Introduced
Introduced in House
U.S. House of Representatives
- May 15, 2026
Introduced
Introduced in U.S. House
U.S. House
- May 15, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 15, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 15, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Read the record
- Read on Congress.gov (opens in a new tab) The official record on Congress.gov.